M
CELUW

Murchinson’s Celularity Inc CELUW Stock Holding History

Murchinson’s Portfolio CELUW Stock Details CELUW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-165,557
Closed -$190K – 150
2021
Q3 		$190K Sell
165,557
-28,343
-15% -$37.9K 0.09% 62
2021
Q2 		$264K Buy
+193,900
New +$233K 0.09% 82

Other funds holding CELUW

LA
Linden Advisors New York $17.9B AUM 1.72% 1-Year Est. Return
ICM
Ionic Capital Management New York $1.37B AUM 48.26% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $24B AUM 37.67% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return
PFM
Privium Fund Management Amsterdam, Netherlands $480M AUM 77.45% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return
CL
CSS LLC Chicago, Illinois $2.09B AUM 59.56% 1-Year Est. Return
DKCM
Davidson Kempner Capital Management New York $7.33B AUM 56.47% 1-Year Est. Return
EPM
Equitec Proprietary Markets Chicago, Illinois $559M AUM 230.29% 1-Year Est. Return
PI
PEAK6 Investments Chicago, Illinois $44.8B AUM 19.99% 1-Year Est. Return

Murchinson's CELUW Position: Q4 2021 in Review

Murchinson sold out of Celularity Inc (CELUW) in Q4 2021, closing a stake of 165,557 shares — an estimated $190K sold.

Murchinson first reported a position in CELUW in Q2 2021 and held it in 2 quarters. The position peaked at $264K in Q2 2021. 21 funds tracked by Wall St. Rank hold CELUW as of Q4 2021.

  • Murchinson reported no remaining Celularity Inc position as of Q4 2021 after selling out during the quarter.
  • Murchinson sold 165,557 Celularity Inc shares in Q4 2021, an estimated $190K.
  • Murchinson first reported a position in Celularity Inc in Q2 2021 and held it in 2 quarters.
  • Murchinson's Celularity Inc position peaked at $264K in Q2 2021.
  • 21 funds tracked by Wall St. Rank held Celularity Inc as of Q4 2021.

Based on Murchinson's 13F filing for Q4 2021, filed 14 Feb 2022.